Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Nov 30, 2023 (filed on Dec 01, 2023)Insider Name:Gelhaus KenOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:3,587Price:$1.73
-
Nov 14, 2023 (filed on Nov 15, 2023)Insider Name:Hood LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:-15,000Price:--
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Terrill DamonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:27,027Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Mackowski J MatthewOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:810,810Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Lowell MatthewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:54,054Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Gunstream StephenOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:54,054Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Telegraph Hill Partners IV, L.P.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:1,190,270Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Telegraph Hill Partners IV, L.P.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:6,917,837Price:$1.85
-
Aug 31, 2023 (filed on Sep 05, 2023)Insider Name:Demski Martha JOwnership Type:Direct OwnershipSecurities:Non-Qualified Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:56,683Price:--
-
Jun 13, 2023 (filed on Jun 14, 2023)Insider Name:Hood LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-11,400Price:$3.80
Filings by filing date
-
Nov 30, 2023 (filed on Dec 01, 2023)Insider Name:Gelhaus KenOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:3,587Price:$1.73
-
Nov 14, 2023 (filed on Nov 15, 2023)Insider Name:Hood LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:J - Other transaction# or value acquired/disposed of:-15,000Price:--
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Terrill DamonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:27,027Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Mackowski J MatthewOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:810,810Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Lowell MatthewOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:54,054Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Gunstream StephenOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:54,054Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Telegraph Hill Partners IV, L.P.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:1,190,270Price:$1.85
-
Sep 19, 2023 (filed on Sep 21, 2023)Insider Name:Telegraph Hill Partners IV, L.P.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:6,917,837Price:$1.85
-
Aug 31, 2023 (filed on Sep 05, 2023)Insider Name:Demski Martha JOwnership Type:Direct OwnershipSecurities:Non-Qualified Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:56,683Price:--
-
Jun 13, 2023 (filed on Jun 14, 2023)Insider Name:Hood LisaOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-11,400Price:$3.80
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 2451 Bert Drive HOLLISTER CA 95023 |
Tel: | N/A |
Website: | https://www.teknova.com |
IR: | See website |
Key People | ||
Stephen Gunstream President, Chief Executive Officer, Director | Matthew C. Lowell Chief Financial Officer | Lisa Hood Chief People Officer |
Damon Terrill Chief Compliance Officer, General Counsel | Ken Gelhaus Chief Commercial Officer |
Business Overview |
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. The Company offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research. |
Financial Overview |
For the nine months ended 30 September 2023, Alpha Teknova Inc revenues decreased 14% to $28.8M. Net loss decreased 24% to $26.1M. Revenues reflect United States segment decrease of 15% to $27.6M. Lower net loss reflects Goodwill impairment decrease from $16.6M (expense) to $0K, General and administrative - Balancing v decrease of 9% to $17M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$1.22 to -$0.90. |
Employees: | 285 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $107.75M as of Sep 30, 2023 |
Annual revenue (TTM): | $36.71M as of Sep 30, 2023 |
EBITDA (TTM): | -$27.71M as of Sep 30, 2023 |
Net annual income (TTM): | -$39.42M as of Sep 30, 2023 |
Free cash flow (TTM): | -$36.30M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 40,727,780 as of Nov 9, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |